Drug class
Amino-acid-derived anti-inflammatory agent; non-NSAID symptomatic osteoarthritis treatment
Mechanism of action
A hydroxyproline derivative that has been reported to reduce leukocyte adhesion to and migration through vascular endothelium, thereby limiting inflammatory-cell accumulation in joints. It does not share the conventional cyclooxygenase-inhibiting mechanism of NSAIDs.
General use cases
- Studied and used in selected countries for symptomatic treatment of osteoarthritis and inflammatory joint disorders; evidence and authorisation vary by jurisdiction.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
